dijous, 30 d’abril del 2015

Skin in the game: Can risk sharing energize medtech?

Everyone wants advances in medical technology, but getting paid for innovation is tough even with the most convincing story about improving care and saving costs. Hospitals are understandably skeptical; can these magical benefits be realized in our institution, or will we just get stuck with the bill? Better to keep doing what we do now, right? As advisors to companies attempting to create and grow markets for new medical technologies, usually without killer data or labeling out the gate, S2N is keenly aware of the current economic realities in healthcare. But we also believe there is measurable value in many med tech innovations. So how do innovators persuade customers, particularly early ones, to take that leap of faith to gain a foothold, or even a toehold, in the market?

read more



from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1dyaK3H

Cap comentari:

Publica un comentari a l'entrada